Progress of Immunotherapy Mechanisms and Current Evidence of PD-1/PD-L1 
Checkpoint Inhibitors for Non-small Cell Lung Cancer with Brain Metastasis

Progress of Immunotherapy Mechanisms and Current Evidence of PD-1/PD-L1 
Checkpoint Inhibitors for Non-small Cell Lung Cancer with Brain Metastasis

Brain metastasis (BM) is a common complication in non-small cell lung cancer (NSCLC), which associates with poor prognosis. Recently, immune checkpoint inhibitors (ICIs) has revolutionized the treatment of tumors. Programmed death-1 (PD-1)/programmed death ligand 1 (PD-L1) inhibitors could produce a...

Full description

Bibliographic Details
Main Authors: Jiamin SHENG, Xiaoqing YU, Hui LI, Yun FAN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2020-11-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
brain metastasis
immunotherapy
pd-1/pd-l1
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.31

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.31

Similar Items